Benjamin Terrier: RCT Shows Rituximab Outperforms Conventional Therapy for Remission Induction in EGPA Annals of Int Med
Benjamin Terrier, Professor of Internal Medicine at Cochin Hospital, Paris Cité University, shared a post on X:
“Thrilled to share our latest RCT in EGPA comparing Rituximab Versus Conventional Therapy for Remission Induction, and published in
Annals of Internal Medicine Journal.
-Thanks to all the amazing French Vasculitis Study Group.”
Read the full article here.
Article: Rituximab Versus Conventional Therapy for Remission Induction in Eosinophilic Granulomatosis With Polyangiitis: A Randomized Controlled Trial
Authors: Benjamin Terrier, Grégory Pugnet, Claire de Moreuil, Bernard Bonnotte, Ygal Benhamou, Dominique Chauveau, Marie-Charlotte Besse, Pierre Duffau, Nicolas Limal, Antoine Néel, Geoffrey Urbanski, Noémie Jourde-Chiche, Nicolas Martin-Silva, Julien Campagne, Arsène Mekinian, Nicolas Schleinitz, Felix Ackermann, Anne-Laure Fauchais, Antoine Froissart, Thomas Le Gallou, Yurdagul Uzunhan, Jean-François Viallard, Alice Bérezné, Laurent Chiche, Camille Taillé, Guillaume Direz, Cécile-Audrey Durel, Pascal Godmer, Salim Trad, Marc Lambert, Mathilde de Menthon, Thomas Quéméneur, Jacques Cadranel, Pierre Charles, Antoine Dossier, Léa Jilet, Loïc Guillevin, Hendy Abdoul, Xavier Puéchal, and the French Vasculitis Study Group
Stay updated with Hemostasis Today.
-
Oct 13, 2025, 03:53Ganesh Mohan is Organising a Webinar to Improve Awareness About Thrombophilia on World Thrombosis Day
-
Oct 13, 2025, 02:47Thomas Reiser: Don't Miss This ISTH Research Recap with Robert Sidonio, Cedric Hermans and Michael Makris
-
Oct 12, 2025, 15:39Renjith Vijayakumar Selvarani: A Heart Attack Isn’t Just a Health Scare — It’s a Medical Emergency
-
Oct 12, 2025, 11:28Is it time for GLP1 receptor agonists in VTE care?
-
Oct 12, 2025, 11:26WFH: Women and Girls with Bleeding Disorders
-
Oct 13, 2025, 03:32Wolfgang Miesbach: This Study from Children's Hospital of Philadelphia Provides Crucial Insights Into Elevidys
-
Oct 13, 2025, 02:43Lukas Meyer and Colleagues on Reperfusion-dependent Treatment Effects of Thrombectomy in Large Ischemic Infarcts
-
Oct 12, 2025, 10:14Hatim Lokhandwala: Landmark HI-PRO Trial Redefines VTE Treatment Guidelines
-
Oct 12, 2025, 07:28Roberta Gualtierotti: rFVIIIFc and rFIXFc Ensured Effective Haemostasis and Favourable Safety in Major Orthopaedic Surgery
-
Oct 12, 2025, 01:32Evaluating Drug–Drug Interactions in Cancer Patients Receiving Anticoagulants and Antineoplastics
-
Oct 13, 2025, 02:46Flora Peyvandi: First Proposed Blood Test for Chronic Fatigue Syndrome - What Scientists Think
-
Oct 13, 2025, 02:44Silvio Maresca: Honored to be part of this international research project - ThrombUS+
-
Oct 10, 2025, 12:25Robert Lewis: T Cells Are Wonderful - But They Can't Do Everything
-
Oct 9, 2025, 13:03Peter Graves: When the Bleeding Does Not Stop
-
Oct 8, 2025, 12:44Bobur Kholikov: Thrombosis Diagnostics with YHLO
-
Oct 13, 2025, 03:44Jorge Monge: It Was An Honor to Take Part in the 3rd EBA Workshop on Rare Blood Provision
-
Oct 13, 2025, 03:15Arun V. J: They Chose Death Over A Blood Transfusion — And Here’s Why I Stopped Judging Them
-
Oct 13, 2025, 03:13Rahaf Ajaj: The Persistent Gender Gap in Nobel Prizes - A Call for Greater Inclusion
-
Oct 13, 2025, 02:50Emmanuel J Favaloro: Again Promoting World Thrombosis Day - October 13
-
Oct 12, 2025, 07:38Antonio Vega With Incredible Team Led by the Great Dr Majluf